STAT+: Pharmalittle: Illumina faces more challenges after winning FTC case; Novo Nordisk buys Forma Therapeutics
Good morning, everyone. I’m Jason Mast, the last of the understudies filling in while Ed is on vacation. On most mornings, I’d be pouring a hot cup, no cream, no sugar, but we’ve got a holiday weekend ahead and I’m out of beans. So I’ll be sipping on a Starbucks cold brew as we go through the news. It’s even got a touch of sweet cream. We’ll be off for Labor Day, and Pharmalittle will at last be back in Ed’s trusty hands come Tuesday.
The Centers for Disease Control recommended new Covid boosters designed to closely match the Omicron variants now in circulation, STAT writes. Director Rochelle Walensky’s sign-off followed a Food and Drug Administration decision Wednesday and a nearly unanimous recommendation yesterday from a panel of outside advisors. The shots will likely reach a pharmacy near you in the coming days.
Continue to STAT+ to read the full story…
